Related Experiment Video
Updated: May 24, 2026

Replication of the Ordered, Nonredundant Library of Pseudomonas aeruginosa strain PA14 Transposon Insertion Mutants
Published on: May 4, 2018
[Multidrug-resistant Pseudomonas aeruginosa T]
1Department of Infectious Diseases, Research Institute, National Center for Global Health and Medicine.
Abstract:
The emergence of Pseudomonas aeruginosa strains resistant to carbapenems, fluoroquinolones and amikacin, which were defined as multidrug-resistant (MDR) strains, is a serious problem in Japan. Nosocomial outbreaks of MDR P. aeruginosa infection have become problematic in hospitals. The percentage of MDR isolates at medical facilities was about 2.5% of P. aeruginosa isolates. Furthermore, clonal expansion of P. aeruginosa strains highly resistant to these antibiotics with MICs of more than 64 microg/mL occurred in community hospitals. Most of these multidrug highly resistant strains produced metallo-beta-lactamase IMP-1 and aminoglycoside 6'-N-acetyltransferase AAC(6')-Iae. An immunochromatographic assay was developed for the rapid detection of these enzymes producing strains. The developed assay is an easy-to-use and reliable detection method for the multidrug highly resistant P. aeruginosa.
Insights
Multidrug-resistant Pseudomonas aeruginosa is a growing threat in Japan, with highly resistant strains producing specific enzymes. An immunochromatographic assay offers a rapid detection method for these problematic bacteria.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Multidrug-resistant (MDR) Pseudomonas aeruginosa strains resistant to carbapenems, fluoroquinolones, and amikacin pose a significant challenge in Japan.
- Nosocomial outbreaks of MDR P. aeruginosa infections are increasingly problematic in healthcare settings.
- MDR P. aeruginosa isolates constitute approximately 2.5% of all P. aeruginosa isolates in medical facilities.
Purpose of the Study:
- To address the challenge of multidrug resistance in P. aeruginosa.
- To develop a rapid detection method for specific enzyme-producing MDR P. aeruginosa strains.
Main Methods:
- Characterization of multidrug-resistant P. aeruginosa strains, focusing on antibiotic resistance profiles.
- Identification of key resistance enzymes, including metallo-beta-lactamase IMP-1 and aminoglycoside 6'-N-acetyltransferase AAC(6')-Iae.
- Development and validation of an immunochromatographic assay for enzyme detection.
Main Results:
- Clonal expansion of P. aeruginosa strains with high-level resistance (MICs > 64 microg/mL) was observed in community hospitals.
- The majority of these highly resistant strains produced metallo-beta-lactamase IMP-1 and aminoglycoside 6'-N-acetyltransferase AAC(6')-Iae.
- The developed immunochromatographic assay demonstrated ease of use and reliability for detecting these enzyme-producing strains.
Conclusions:
- The emergence of highly resistant MDR P. aeruginosa strains is a critical issue in Japan.
- The developed immunochromatographic assay provides a valuable tool for the rapid identification of these specific resistant strains.
- This assay can aid in infection control and timely management of MDR P. aeruginosa outbreaks.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Atypical Pneumonia
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Development of Antibiotic Resistance
Gene Regulation in Microbial Communities: Quorum Sensing

